Labopharm Announces its Once-Daily Tramadol Approved for Sale in Canada.

0 Comments | M2 Presswire, June, 2007

M2 PRESSWIRE-18 June 2007-Morning Movers: Labopharm Announces its Once-Daily Tramadol Approved for Sale in Canada(C)1994-2007 M2 COMMUNICATIONS LTD RDATE:18062007 Market Gainer is quickly emerging as the one stop shop for international small-cap investors looking to stay a step ahead of the markets.

Activity on the Toronto market has brought this company to the attention of our research team. Labopharm Inc. (TSX: DDS), is responding to the attention of investors. Our goal is to create a community of international investors who consistently and effectively capitalize on the enormous gains the small-cap Canadian and American exchanges offer. June 18 - Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today announced that it has received a Notice of Compliance (NOC)...

Read the rest of this article with a Free Trial at HighBeam Research.
Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research
 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:
  1. You are currently: a Guest |
  4.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)